ESR1 and breast carcinoma: To address this knowledge gap, the present study identifies and characterizes a previously unrecognized WISP1/Src/MIF signaling axis that regulates hyaluronan (HA) metabolism, EMT, and invasive behavior in ER+ breast cancer cells, providing novel mechanistic insights and potential avenues for therapeutic intervention.